Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST

Authors

Hsiang-Chih Lu, Washington University School of Medicine in St. Louis
Vanessa Eulo, Washington University School of Medicine in St. Louis
Anthony J. Apicelli, Washington University School of Medicine in St. Louis
Melike Pekmezci, University of California, San Francisco
Yu Tao, Washington University School of Medicine in St. Louis
Jingqin Luo, Washington University School of Medicine in St. Louis
Angela C. Hirbe, Washington University School of Medicine in St. Louis
Sonika Dahiya, Washington University School of Medicine in St. Louis

Journal

Oncotarget

Publication Date

5-1-2018

Volume

9

Issue

33

First Page

23018

Last Page

23028

Document Type

Open Access Publication

DOI

10.18632/oncotarget.25195

Rights and Permissions

Rajput S, Guo Z, Li S, Ma CX. PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer. Oncotarget. 2019 Jun 4;10(38):3667-3680. eCollection 2019 Jun 4. https://doi.org/10.18632/oncotarget.25195. Copyright: Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Lu, Hsiang-Chih; Eulo, Vanessa; Apicelli, Anthony J.; Pekmezci, Melike; Tao, Yu; Luo, Jingqin; Hirbe, Angela C.; and Dahiya, Sonika, "Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST." Oncotarget. 9, 33. 23018 - 23028. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/8992